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The formation of reovirus double-stranded (ds) RNA and of oligo adenylic acid
(oligo A) is inhibited by 5 ug of actinomycin D per ml added at the time of viral
infection. Viral proteins are synthesized and assembled into dsRNA-deficient
particles under these conditions. The addition of cycloheximide to infected cells
during the mid-logarithmic phase of viral replication terminates protein and
dsRNA synthesis, but allows continued oligo A synthesis for about 1 h. The
3H-labeled oligo A formed in the presence of cycloheximide is incorporated into
particles whose density in CsCl is identical to that of reovirions. Using the large
particulate or virus factory-containing cytoplasmic fraction of infected L-cells, we
have established an in vitro system for the synthesis of oligo A. The in vitro
product migrates slightly faster in sodium dodecyl sulfate acrylamide gels than
marker oligo A. Oligo A synthesis in vitro continues for about 1 h, requires the
presence of only one ribonucleoside triphosphate (ATP), is not inhibited by
DNase or RNase, but is abruptly terminated by the addition of chymotrypsin to
the reaction mixture. Oligo A formed both in vivo and in vitro is released from the
factory fraction by chymotrypsin digestion. The enzymes which catalyze the
synthesis of oligo A, dsRNA, and single-stranded RNA all exhibit a similar
temperature dependence with an optimum of -45 C. These results indicate that
oligo A is formed within the core of the nascent virion after the completion of
dsRNA synthesis; they suggest that the oligo A polymerase is an alternative
activity of the virion-bound transcriptase and that it is regulated by outer
capsomere proteins.
Approximately 20% of the RNA contained
within reovirus is a single-stranded oligomer, 6
to 20 nucleotides in length, which is composed
principally of adenylic acid (5-7, 19, 23, 29).
Each virion contains about 1,200 molecules of
these adenine-rich oligoribonucleotides regard-
less of the temperature at which the virus is
grown (7) or the cell type in which it replicates
(5). Despite the abundance of these adenylic
acid oligomers (oligo A) in reovirus, virtually no
information is available concerning the mecha-
nism and intracellular location of its synthesis,
its functional role, if any, in the formation of
viral single- and double-stranded RNAs, its
precise location within the virion, and its impor-
tance in the viral replicative cycle. For these
reasons, we have examined the synthesis of viral
oligo-adenylic acid in vivo and in vitro.
MATERIALS AND METHODS
Cells and virus. L-strain mouse fibroblasts were
grown in suspension culture and infected with reovi-
'Present address: Banting and Best Department of Medi-
cal Research, University of Toronto, Ontario, Canada.
rus type 3 as described previously (18).
Purified 3H-leucine-labeled reovirus was prepared
as described (24).
Preparation of the large particulate cytoplasmic
fraction (LPF). Infected L-cells were sedimented at
500 x g at 4 C, washed twice with cold phos-
phate-buffered saline (PBS) (13), resuspended in -8
ml of 0.14M NaCl, 0.01 M Tris (pH 8.4), 0.0015 M Mg
acetate, 0.5% NP-40 (Shell Chemical Co.), and dis-
rupted with a dounce homogenizer. The homogenate
was centrifuged at 1,000 x g for 10 min at 4 C, and the
supernatant fraction was removed and stored at 4 C.
The pellet fraction was resuspended in 3 to 4 ml of
homogenization buffer, and was centrifuged as before.
The supernatants from both centrifugations were
combined and centrifuged at 20,000 x g at 4 C for 20
min in a Sorvall centrifuge. The resulting pellet,
which contains the virus factories, was resuspended in
reticulocyte standard buffer (RSB) (32) and used as
the source of enzyme for RNA synthesis.
Synthesis of RNA in vitro. In vitro synthesis of
single-stranded (ssRNA), double-stranded (dsRNA),
and oligo A was carried out as described (1), with the
following exceptions. (i) Phosphoenolpyruvate (10
mM), pyruvate kinase (25 tLg/ml), and actinomycin
D (10 ,g/ml) were added to all reaction mixtures. (ii)
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mixture whenever ssRNA synthesis was monitored.
(iii) Oligo A synthesis was measured with 0.5 mM 3H-
ATP (S.A. 200 uCi/mM) as the only nucleotide. Un-
less otherwise noted, all incubations were for 30 min
at 37 C.
Analytical procedures. RNA was extracted with
sodium dodecyf sulfate (SDS)-phenol by the method
of Tavitian et al. (30) and analyzed as described in the
text.
Methylated albumin-silicic acid columns were pre-
pared as previously described (23, 25).
Polyacrylamide gel electrophoresis. (i) Proteins.
Viral proteins were analyzed in 10% acrylamide,
0.27% bisacrylamide gels in 0.1% SDS, 6 M urea, 0.1
M NaPO4 (pH 7.2), 0.02M NaEDTA as described (24),
28, 36). Samples were prepared as described in the
text, solubilized in dissociation buffer (DB) in the
presence of 6 M urea at 100 C for 1 min, and run at 5
mA/gel. Gels were cut into 0.9-mm segments, solubi-
lized with 0.25 ml of Soluene (Packard) for each
0.9-mm segment, and assayed for radioactivity as
described (24).
(ii) RNA. Oligo A and dsRNA were assayed in 10%
acrylamide, 0.27% bisacrylamide gels in 0.1% SDS,
0.1 M NaPO4 (pH 7.2), 0.02 M NaEDTA as originally
described by Bellamy et al. (5). Samples were pre-
pared as described in the text, solubilized in DB (24)
at 37 C for 1 h, and run at 6 mA/gel. Gels were cut into
0.9-mm segments (four adjacent segments were com-
bined in each fraction) and assayed for radiolabel as
described above for proteins.
Electron microscopy. Cells were fixed, processed,
and examined as described (25).
RESULTS
Formation of Oligo A in vivo: (i) Effect of
inhibitors of RNA synthesis. To determine
whether viral oligo A synthesis is dependent
upon the formation of cellular poly A, we used
the adenosine analog cordycepin (3 deoxyaden-
osine), an inhibitor of cellular poly [A] synthesis
(12). Cordycepin at a concentration of 50 ug/ml
reduces the incorporation of 3H-uridine and
3H-adenosine into cellular RNA by 60 and 66%,
respectively (Table 1). Oligo A synthesis is
unaffected by this compound, whereas reovirus
replication is somewhat reduced (Table 1).
Therefore, it seemed unlikely that viral oligo A
synthesis and cellular poly [A] synthesis are
linked.
Actinomycin D at concentrations above 0.5
ug/ml inhibits reovirus replication in L-cells
(22) To determine whether the actinomycin-
mediated inhibition of reovirus replication is
linked to inhibition of viral oligo A synthesis by
this antibiotic, L-cells were infected with reovi-
rus in the presence of 0.3 Mig of actinomycin D
per ml, and at various times after infection the
actinomycin concentration was increased to 5
Mg/ml. The cells were incubated with 3H-adeno-
sine from 9 to 10 h after infection, and the
distribution of radiolabel in oligo A and viral
dsRNA was measured (Table 2). When the
actinomycin concentration was increased from
0.3 to 5 Ag/ml 4 h after infection, dsRNA
synthesis 9 to 10 h after infection was reduced to
33% of the control value, whereas oligo A
synthesis was decreased to 56% of control. In
contrast, when the actinomycin concentration
was increased 8 h after infection, nearly normal
amounts of dsRNA and oligo A were formed.
Polyacrylamide gel electrophoretic analysis of
the radiolabeled viral proteins in cells treated
with 0.3 and 5 ,g of actinomycin per ml revealed
no qualitative differences in the viral proteins
synthesized (Fig. 1). An electron microscope
examination of reovirus infected cells treated
with 5 ug of this antibiotic per ml showed small
viral factories containing a large proportion of
empty particles. (Fig. 2b).
These data provide no support for a selective
inhibition of viral oligo A synthesis by ac-
tinomycin; rather, they suggest that dsRNA
synthesis, and not the formation of oligo A, is
primarily affected by high concentrations of
actinomycin.
(ii) Effect of inhibition of protein synthesis.
Cycloheximide causes prompt cessation of
dsRNA formation in reovirus infected L-cells;
TABLE 1. Effect of cordycepin (50 ,ug/ml) on cellular
RNA synthesis, oligo A synthesis, and reovirus
replication
Incorporation of
3H-nucleosides into Incorporation of
cellular RNA (% unin- 'H-adenosine Viral yield




40 34 98 60
a Separate cultures of L-cells (106 cells per 60-mm
petri dish) were incubated for 30 min at 37 C in
medium with or without cordycepin (50 gg/ml).
'H-uridine or 3H-adenosine (3.3 MCi/ml) was added to
duplicate cultures; the cells were incubated for an
additional 3.5 h and assayed for their content of
acid-insoluble radioactivity.
b Cordycepin was added to 5 x 106 cells in suspen-
sion culture 11 h after infection with reovirus (-15
PFU/cell). 15 min later 3H-adenosine (1.5 ACi/ml)
was added to the medium and the cells were incu-
bated for an additional 1 h at 37 C. A large particulate
cytoplasmic fraction was prepared and assayed by
polyacrylamide gel electrophoresis for its content of
oligo A.
cL-cells were infected with reovirus (20 PFU/cell)
and incubated in the presence or absence of cor-
dycepin for 14 h. The cultures were assayed for their
viral content by plaque assay.
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TABLE 2. Effect of actinomycin D (5 Ag/ml) on the synthesis of reovirus dsRNA and oligo A in ViVoa
Actinomycin dsRNA dRAM Oligo A OlgA Viayed(Ag/n)my (counts/min) dsRNA(%) (counts/min) OligoA(%) Viralyield(%)
0.3 36,000 100 22,100 100 100
0.3 to 5, 4 h 12,000 33 12,400 56 NDb
0.3 to 5, 8 h 34,000 95 20,100 91 ND
5 <500 <1 <250 < 1 2
a Portions of 4 x 107 cells were incubated for 1 h with 0.3 or 5 ug of actinomycin D per ml. The cells in each
sample were then concentrated by centrifugation and infected with reovirus (MOI = 25 PFU/cell) at 4 C for 2 h.
The cells were resuspended in warm medium (37 C) containing either 0.3 or 5 jg of actinomycin per ml
and were incubated at 37 C. After 4 and 8 h of infection, the actinomycin concentration of the appropriate sample
was increased to 5 ug/ml. All samples were labeled with 'H-adenosine (2 MCi/ml) from 9 to 10 h after infection.
An LPF was prepared from each sample and its RNA was extracted and precipitated with ethanol. dsRNA was
separated by CF 11 chromatography, re-precipitated with ethanol, and assayed as RNase (8 jig/ml) resistant
acid-insoluble radioactivity as described previously (15). Oligo A was assayed by SDS polyacrylamide gel
electrophoresis. Viral yield was measured by plaque assay.
'ND, Not done.
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FIG. 1. SDS-urea polyacrylamide gel
retic analysis of "C-labeled proteins in
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actinomycin for 1 h and then infected u
(20 PFU/cell) in the presence of this ant
cells were incubated at 37 C in actinomy
ing medium for 8.5 h, at which tim
3H-leucine per ml was added to the cult
0.5-h labeling period the cells were har
cytoplasmic extracts were prepared as c
Zweerink et al. (21), precipitated with c
analyzed by SDS-urea polyacrylamide g
8000 the synthesis of viral ssRNA, however, contin-
ues unabated after the addition of this antibi-
7000 otic (33). We took advantage of these observa-
tions to determine whether oligo A synthesis is
6000 dependent upon the continued synthesis of
14CcpC cpm proteins or of dsRNA, or both. Infected L-cells
4000 were tested for their ability to incorporate
3H-adenosine into oligo A at various times after
2000 the addition of cycloheximide to the culture.
Although viral replication is inhibited by cy-
cloheximide, oligo A synthesis proceeds nor-
mally for about 1 h after the addition of this
6000 antibiotic (Fig. 3a), and then stops. As ex-
C cpm pected, progeny virus and oligo A continue to be
4000 formed in the control culture throughout the
course of the experiment (Fig. 3b).
2000 To determine whether the oligo A formed in
the presence of cycloheximide was incorporated
into reovirions, an experiment similar to the one
just described was performed, and the radio-
ooo0 labeled virus was purified and centrifuged to
3H cpm equilibrium in CsCl gradients (Fig. 4a,b). Dur-
ing a 1-h labeling period nearly equal amounts
500 of 3H-adenosine were incorporated into particles
from the control and cycloheximide-treated cul-
tures (Fig. 4 a,b). These particles exhibited a
buoyant density of 1.37 g/cm3. Polyacrylamide
electropho- gel analyses of the 3H-labeled RNA contained
reovirus In- within these particles showed that 97% of the
orf Lcells (5f 3H-adenosine incorporated into virions in the
treated with presence of cycloheximide was contained in
vith reovirus oligo A (Table 3). In contrast, virions formed in
tibiotic. The the absence of cycloheximide incorporated 3H-
icin-contain-






cells treated with 0.3 jig of actinomycin per ml; total
counts per minute incorporated = 385,040. Panel b,
cells treated with 5.0 Mg of actinomycin per ml; total
counts per minute incorporated = 325,500. Panel c,
3H-leucine-labeled reovirus.
0
742 SILVERSTEIN ET AL. J. VEROL.
 o
n








REOVIRUS OLIGO A SYNTHESIS IN VIVO AND IN VITRO
adenosine into both dsRNA and oligo A. The
distribution of 3H-adenosine between dsRNA
and oligo A varied, depending upon the length
of the labeling period. (Table 3).
Previous studies have established the follow-
ing. (i) The adenylic acid residues in reovirus
RNA are nearly equally divided between
dsRNA and oligo A molecules (23). (ii) dsRNA
is formed by the synthesis of "minus" strands
on preformed "plus" strand templates (21). The
"plus" strands which serve as templates for
dsRNA accumulate during the beginning of the
replicative cycle. Hence, the dsRNA formed
late in the replicative cycle (i.e., after the 8th or
9th h of infection) is labeled exclusively in the
minus strand (1). (iii) Synthesis of minus
strands on plus strand templates occurs within
the "core" of the nascent virion (1, 20, 37).
From these data and those reported in Fig. 3
and Table 3, it is possible to determine the order
of incorporation of dsRNA and oligo A into
reovirions.
If oligo A and dsRNA are incorporated into
virions concurrently during viral replication,
then 3H-adenosine should label these two
classes of molecules in a ratio of 1:2, dsRNA:
oligo A (Fig. 5a). However, if the incorporation
of dsRNA either precedes or follows the incorpo-
ration of oligo A during viral maturation, then
the ratio of 3H-adenosine-labeled dsRNA: oligo
A in mature virions should vary with the length
of the labeling period. If dsRNA is incorporated
into nascent virions before oligo A, the ratio of
3H-adenosine-labeled dsRNA: oligo A should
increase as the length of the labeling period
increases (Fig. 5b). Conversely, if dsRNA is
incorporated into nascent virions after oligo A,
then the ratio of 3H-adenosine-labeled dsRNA:
oligo A should decrease with increased time of
labeling (Fig. 5c). The results of the experiment
reported in Fig. 3 and Table 3 indicate that
dsRNA is incorporated before oligo A, support-
ing the model described in Fig. 5b. The presence
of 3H-adenosine-labeled oligo A in virions con-
taining unlabeled dsRNA (Fig. 3a, and Table 3,
line a) is also in agreement with this model.
Synthesis of oligo adenylic acid in vitro. To
examine the synthesis of viral oligo A directly
we established a cell-free system by using the
large particulate or virus factory-containing
fraction of reovirus-infected cells (1, 25). (This
fraction has been identified as the site of
reovirus ss- and dsRNA synthesis [1, 20, 34,
37]). The large particulate fraction incorporates
a-32P-labeled ATP into oligo A. The product
formed under these conditions migrates in poly-
acrylamide gels together with or slightly faster
than oligo A extracted from purified reovirus
(Fig. 6).
The specificity of the oligo A synthesizing
enzyme for adenylic acid was examined by
adding each of the other three radiolabeled
ribosomal nucleoside triphosphates (rNTP's)
to the reaction mixture. 3H-CTP or 3H-GTP are
not incorporated into a polynucleotide sim-
ilar in size to oligo A (Fig. 7). A small amount
of 3H-UTP is incorporated into a polynucleo-
tide which co-electrophoreses with oligo A
(Fig. 7).
To gain further information about the struc-
ture and base composition of these in vitro
synthesized oligonucleotides, oligo A was syn-
thesized by using 3H- or a-32P-labeled ATP.
The oligonucleotide products of these reactions
were purified, and then hydrolyzed with alkali;
the resulting radiolabeled nucleotides were ana-
lyzed by paper electrophoresis and compared
with the alkaline hydrolysis products of in vivo
synthesized 3H-adenosine-labeled oligo A
(Table 4). Eighty percent of the radiolabel in
the in vivo synthesized oligo A co-electro-
phoresed with AMP and 10% co-electrophoresed
with adenosine. Five percent of the label mi-
grated together with, or slightly ahead of, ADP
and ATP, and was identified as pAp and ppAp
(Table 4). In contrast, in two separate experi-
ments, 52 and 71% of the radiolabel in the in
vitro synthesized oligo nucleotides co-electro-
phoresed with adenosine, 40 and 20% of the
radiolabel was recovered as AMP, and less than
10% was identified as pAp, ppAp, and pppAp. A
similar analysis of in vitro synthesized a-32P-
ATP-labeled oligo A showed that 67% of the
radiolabel was incorporated into AMP, 32.5%
into UMP, and 0.5% into ppAp (Fig. 8 a and b).
To be certain that the radiolabeled compound
identified at pH 3.5 as UMP was a pyrimidine,
and not a phosphorylated purine, the nucleo-
tides were hydrolyzed in acid prior to electro-
phoretic analysis. Under these circumstances no
radiolabel co-migrated with AMP, whereas the
radiolabel in UMP was conserved (data not
shown).
Several important conclusions may be drawn
from these data. (i) The oligo A polymerase
incorporates ATP into an adenylic acid-rich
polymer in vitro. (ii) A minor proportion (less
than 10%) of these in vitro synthesized oligo-
mers are formed ab initio since they contain
pAp, ppAp, or pppAp at their 5' termini. (iii) A
moderate proportion (between 20 and 40%), of
the 3H-ATP incorporated in vitro resides in
internal linkages, since 20 to 40% of the nucleo-
tides in an alkaline hydrolysate are recovered as
3H-AMP. (iv) A major proportion (52 to 71%) of
the radiolabeled ATP is incorporated into the 3'
termini of preformed oligonucleotides and re-
flects chain termination. (v) One third of the
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Synthesis of oligo A, in contrast to the synthe-
sis of dsRNA, proceeds in vitro for over an hour,
suggesting that these two biosynthetic events
are not closely linked (Fig. 9). That oligo A
synthesis is indeed independent of dsRNA syn-
thesis and of the presence of ssRNA templates
'Control was confirmed by measuring the amount of
oligo A formed after addition of nucleases to the
reaction mixture at the beginning of the incuba-
tion. RNase, which inhibits dsRNA formation
by destroying template plus strands (1), had no
effect upon the amount or size of the oligo A
formed. Similar results were obtained when
20y/ml DNase was added to the reaction mixture.
cycloheximide Effect of chymotrypsin. The enzymes which
hr
5 l'o 5 20
Fract'ion no.
FIG. 3. Effect of cycloheximide on the synthesis of
reovirus oligo A. L-cells (2 x 108) were infected with
reovirus (25 PFU/cell) and incubated in medium
containing 0.3 Aug of actinomycin per ml for 9 h. The
cells were then divided into two portions. Cyclohexi-
mide (20 ,g/ml) was added to one portion and 15 min
later 3H-adenosine (3 tiC/ml) was added to both
samples. At 1, 2, and 4 h after addition of cyclohexi-
mide the cells were harvested from cycloheximide-
treated (a) and control (b) cultures, and were assayed
for their content of oligo A as described in Materials
and Methods. BB, Bromophenol blue dye marker. At
suitable intervals (9, 12.25 and 13.25 h after infec-
tion), samples were also taken from the control and
cycloheximide-treated cultures and monitored for
their content of infectious virus (insert c).
a-32P-ATP is incorporated into an oligonucleo-
tide containing the sequence UpA but lacking
the sequences CpA or GpA.
Previous work (1) established that the large
particle fraction catalyzed synthesis of dsRNA
proceeds for a limited time (10 to 15 min) and is
inhibited by adding RNase to the reaction
mixture at the beginning of the incubation. We
took advantage of these observations to deter-
mine whether the in vitro synthesis of oligo A is
linked to the formation of dsRNA, and whether





p 4 8 12 p 4 8 12
Fraction number
FIG. 4. Effect of cycloheximide on the incorpora-
tion of oligo A into reovirus. L-cells (4 x 108) were
infected with reovirus (MOI = 5 PFU/cell) and
incubated in medium containing 0.3 Ag of ac-
tinomycin per ml for 11 h. The cells were then divided
into three portions at a concentration of 3.3 x 106
cells/ml. Cycloheximide (20 Ag/ml) was added to one
portion, and 10 min later 3H-adenosine (10 MCi/ml)
was added to all three samples. The cycloheximide-
treated portion and one portion of the control cells
were harvested after a 1-h labeling period. The cells in
the second control culture were collected after a 2-h
labeling period. Virus contained in each sample was
then purified and centrifuged to equilibrium in CsCI
gradients as described (24). The gradients were frac-
tionated and the radiolabel in each fraction was
measured.
FIG. 2. Electron microscopy of reovirus factories in L-cells incubated in either 0.3 or 5.0 Mg of actinomycin
per ml. a, L-cells were treated with 0.3 Ag of actinomycin per ml for 1 h prior to infection with reovirus (250
PFU/cell). The infected cells were incubated at 37 C in medium containing 0.3 Mig of actinomycin per ml for 12.5
h, harvested, and processed for electron microscopy. b, Reovirus-infected L-cells were treated as described in
Fig. 3a except that 5 Ag of actinomycin per ml was used throughout. Note the large proportion of particles lacking
electron-dense dsRNA cores, and the "empty" particles (arrows) containing small electron-opaque structures at
their centers. These centrally located electron-opaque structures may represent the ssRNA's which serve as


















TABLE 3. Distribution of 3H-adenosine between dsRNA and oligo Aa
Time of 3H- Total counts/ Counts/min Recovered Recovered Ratio
adenosine Cyclohexi- min applied recovered Counts/min counts/min Counts/min counts/min counts/min
labeling (h) i to gel on gel In oligo A in oligo A in dsRNA in dsRNA dsRNA/label ngh)mid
~~~ ~(%)(%) oligo A
1 + 64,330 57,932 56,406 97.4 1,516 2.6 0.027
1 _ 72,530 66,328 57,886 87.3 8,442 12.7 0.15
2 _ 121,500 103,647 83,181 80.3 20,446 19.7 0.24
a The peak fractions (8 to 11) of each of the CsCl gradients described in Fig. 5 were combined and dialyzed
overnight against 0.15 M NaCl. The RNA was extracted with SDS-phenol and precipitated with alcohol. The
precipitated RNA was dissolved in 500 iliters of dissociation buffer and 100-,uliter portions of each sample were
analyzed on 10% acrylamide gels. Under these conditions all of the dsRNA remains near the origin of the gel,
whereas oligo A migrates ahead of the bromophenol blue dye marker. The amount of radiolabel in each species of
RNA was assayed as described in Materials and Methods.
Time af ter addition of 3H-odenosine catalyze the synthesis of reovirus ss- and
lh 2h 4h ratio dsRNA's are resistant to chymotrypsin diges-
tion (1, 3, 27). To determine whether the
Coordinate synthesis enzyme(s) which catalyzes oligo A synthesis is












FIG. 5. Models of the radiolabeling pattern of
dsRNA and oligo A. Symbols: radiolabeled
molecules; -----, unlabeled molecules.
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FIG. 6. Size comparison of in vivo and in vitro
synthesized oligo A by acrylamide gel electrophoresis.
An LPF from 6 x 101 L-cells infected for 14 h with
reovirus (MOI = 20 PFU/cell) was suspended in 1.5
ml of RSB. A 0.2-ml amount of this material was
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FIG. 7. Nucleotide specificity of the oligo A po-
lymerase. An LPF prepared from 8 x 10' L-cells
infected for 13 h with reovirus (MOI = 70 PFU/cell)
was suspended in 2 ml of RSB. Four 0.4-ml portions of
this material were incubated separately for 30 min
(total volume of each reaction mixture = 1.6 ml) with
the usual concentrations of salts and buffers contain-
ing 0.5 mM of only one nucleoside triphosphate
(either 3H-ATP, 3H-GTP, 3H-CTP, or 3H-UTP [200
ACiIgmol ]). The reaction mixtures were then cen-
trifuged at 20,000 x g for 30 min at 4 C, and the RNA
in the resulting pellets was extracted with SDS-
phenol, precipitated with ethanol, dissolved in DB,
and analyzed on 10% SDS-acrylamide gels.
200 uCi of a-32P-ATP (specific activity 200 MCi/MM).
After 30 min, 3H-adenosine-labeled RNA extracted
from reovirus was added. The mixture was precipi-
tated with 5% trichloroacetic acid, and the precipitate
was washed with ethanol, dissolved in DB, and
analyzed on 10%/ SDS gels.
rNTP-H3
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TABLE 4. Electrophoretic analysis of the nucleotide composition of reovirus oligoribonucleotides labeled in vivo
and in vitro
Adenosine AMP pAp ppAp pppAp
Product analyzed Label Counts/ Counts/ Counts/ Counts/ Counts/
min min min min min
In vivo synthe- 'H-adenosinea 397 12 2,540 76 220 6.5 190 5.5
sized oligo A
In vitro synthe- 3H-ATPb 2,320 71 635 20 140 4 170 5
sized oligo A 3H-ATPC 1,590 52 1,245 40 220 7
a Reovirus-infected cells (5 x 108; MOI = 10 PFU/cell) in medium containing 0.3 ug of actinomycin D were
labeled with 'H-adenosine from 11.5 to 14.5 h after infection. The RNA contained in the LPF of these cells was
extracted, alcohol-precipitated, resuspended in 0.01 M NaH2PO4 (pH 7.2), and analyzed by electrophoresis
in SDS-polyacrylamide gels. The gel fractions containing 'H-oligo A were incubated for 12 h at 37 C in 0.3 N
KOH. The alkaline digest was neutralized with 70% perchloric acid and centrifuged, and the clear supernatant
was spotted on Whatman 3 MM paper and electrophoresed at 220 V for 20 h in 0.02 M Na citrate buffer (pH 4.5).
The paper was cut into 1-cm segments and the radiolabeled nucleotides were eluted with water and counted in
Aquasol. Identity of labeled nucleotides was established by comparison with known standards.
'An LPF was prepared from 5 x 108 L-cells 14.5 h after infection (MOI = 15 PFU/cell). The LPF was
resuspended in 1 ml of RSB and incubated at 45 C for 30 min in a 5-ml reaction mixture containing 0.5 mCi
of 3H-ATP and the usual concentrations of other components. The reaction was terminated by centrifugation at
12,000 rpm at 4 C in a Sorvall SS34 rotor, and the RNA in the pellet fraction was extracted and precipitated.
Oligo A was separated by gel electrophoresis and its content of radiolabeled nucleotides was analyzed as
described above.
"An LPF was prepared from 2 x 109 L-cells 13 h after infection (MOI = 25 PFU/cell). The LPF was
resuspended in 8 ml of RSB and incubated at 37 C in a 20-ml reaction mixture containing 2.5 mCi of 3H-ATP.
The reaction was terminated and RNA was extracted as described in b above. RNA was chromatographed on a
methylated albumin silicic acid column (60 by 6 mm) equilibrated with 0.1 M NaCl, 0.02 M NaPO4 (pH 7.1). The
RNA was eluted with 0.8 M NaCl in the same buffer, dialyzed versus RSB, and precipitated with alcohol, and its
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FIG. 8. Electrophoretic analysis of an alkaline hy- FIG. 9. Time course of oligo A synthesis in vitro.
drolysate of oligonucleotides synthesized in vitro with Three 0.2-ml samples of the LPF described in Fig. 7
a- 2P-A TP. An LPF was prepared from 2 x 109L-cells were incubated for oligo A synthesis in separate 1-ml
infected for 13.5 h (MOI = 3 PFU/cell). The LPF was reaction mixtures for 10, 30, or 60 min, and cen-
resuspended in 2 ml of RSB and incubated for oligo A trifuged at 20,000 x g for 30 min at 4 C. The pellet
synthesis in a 10-ml reaction mixture containing 100 fractions were resuspended in 1 ml of RSB, precipi-
uCi of a-32P-ATP per ml at 41 C for 30 min. RNA was tated with 5% trichloroacetic acid, washed with etha-
extracted and processed, and the nucleotides were as- nol, dissolved in DB, and analyzed on 10'%0 SDS-
sayed as described in Table 4a. Electrophoresis in acrylamide gels. The radiolabel under each oligo A
0.02MNa citrate, pH 4.5; b, electrophoresis in 0.02M peak was combined, corrected for background, and
Na citrate, pH 3.5. plotted versus time.
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large particle fraction was incubated with chy-
motrypsin and then assayed for its capacity to
catalyze the incorporation of 3H-ATP into oligo
A. Chymotrypsin abolished oligo A synthesis
(Fig. 10) but, as expected, enhanced the overall
incorporation of 3H-ATP into acid-insoluble
products when all four ribonucleoside triphos-
phates were present, thus the enzyme(s) re-
sponsible for oligo A synthesis differs in its
chymotrypsin sensitivity from the enzyme(s)
responsible for the formation of ss- or dsRNA's.
Chymotryptic digestion of intact reovirus re-
moves the outer layers of viral capsomeres and
releases the particle-bound oligo A (3, 14, 29).
We took advantage of these observations to
identify the location of the oligo A synthesized
in vitro within the virus factory.
A large particle fraction was incubated with
3H-ATP and then divided into two samples.
One sample was digested with chymotrypsin.
The samples were then centrifuged and the
supernatant and pellet fractions were assayed
for their content of oligo A. The 3H-labeled oligo
A in the sample that had not been exposed to
chymotrypsin remained in the sedimentable
fraction (Fig. lla). However, the 3H-oligo A in
the sample incubated with chymotrypsin was
released into the supernatant fraction (Fig.
llb). The capacity of chymotrypsin to release in
vitro synthesized oligo A from the large particle
fraction was compared with the ability of this
9
- chymo ( *-*)
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FIG. 10. Effect of chymotrypsin on oligo A synthe-
sis in vitro. An LPF was prepared from 8 x 108 cells
infected for 14 h with reovirus (MOI = 20 PFU/cell)
and resuspended in 2 ml of RSB. Two 0.5-mI portions
were incubated for oligo A synthesis in separate
3.0 ml reaction mixtures. Chymotrypsin (100 ,ug/ml)
was added to one mixture at the start of the reaction.
The reaction was terminated by addition of SDS.
RNA was extracted with phenol, precipitated with
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FIG. 11. Effect of chymotrypsin on the location of
in vitro synthesized oligo A. An LPF was prepared as
described in Fig. 11 and incubated for oligo A synthe-
sis in a 12-ml reaction mixture. The reaction mixture
was then centrifuged at 20,000 x g for 30 min at 4 C,
and the pellet was resuspended in 2 ml of RSB and
divided into two portions. Chymotrypsin (100 ug/ml)
was added to one portion and both samples were
incubated for 15 min at 37 C. The samples were again
centrifuged at 20,000 x g for 30 min at 4 C and each
sample was divided into pellet (a) and supernatant
(b) fractions. 7he RNA in these fractions was ex-
tracted, precipitated with ethanol, and analyzed on
10% SDS acrylamide gels.
enzyme to release oligo A from a similar fraction
labeled in vivo with 3H-adenosine. The in vivo
synthesized oligo A was completely released
from the large particulate fraction by chymo-
trypsin digestion (data not shown) regardless of
whether the chymotrypsin digestion was carried
out in the presence of RSB (low salt) or the oligo
A reaction mixture (high salt). The effect of
chymotrypsin on the large particulate fraction
of reovirus-infected cells was monitored directly
by polyacrylamide gel electrophoretic analysis
of the protein content of this fraction before and
after chymotrypsin digestion. The principal
viral polypeptides remaining in the large parti-
cle fraction after chymotrypsin digestion were
Xl, X2, A1, 6 (24), and a2. Thus, the effect of
chymotrypsin on the large particle fraction
resembles the effect of this enzyme upon the
intact virion. In both cases the core polypep-
tides are retained and the outer capsid proteins
are removed.
To further confirm the presence of oligo A
within virion-like particles an LPF was incu-
bated with 3H-ATP for oligo A synthesis. The
particles were concentrated by centrifugation
and resuspended in TL buffer (26), and then
layered over 0.3 ml of 0.25 M sucrose which
itself overlays a continuous CsCl gradient. The
gradient was centrifuged at 4 C for 3 h at 37,000
rpm in an SW 50.1 rotor. A major proportion of
the radiolabel remained at the sucrose CsCl
interface, but a small proportion sedimented
a Pellet b Supernotont


















REOVIRUS OLIGO A SYNTHESIS IN VIVO AND IN VITRO
into the CsCl gradient and was recovered at a
density of 1.36 to 1.38 g/cm3. When the radiola-
beled particles in these fractions were again
centrifuged to equilibrium in CsCl, a sharp peak
of radiolabel was recovered at a density of 1.365
g/cm3.
Temperature optimum of oligo A synthesis.
The particle-bound ssRNA transcriptase ex-
hibits the unusual temperature optimum of 45
to 50 C (15). We took advantage of this finding
to explore the relationship between the en-
zyme(s) catalyzing the synthesis of ss- and
dsRNA and of oligo A. All three biosynthetic
activities show increased activity at 45 C (Fig.
12 a,b,c), and comparison of the temperature
dependence of these three activities shows that
they increase in parallel to one another.
DISCUSSION
Actinomycin at a concentration of 5 ug/ml
strongly inhibits the formation of reovirus
dsRNA and of oligo A (Table 2). All known
species of reovirus polypeptides are formed in
the presence of high concentrations of this
antibiotic (Fig. 1), and these proteins have been
shown to form particles, some of which may
contain ssRNA precursors of dsRNA (Fig. 2b).
These data, when viewed together with the fact
that synthesis of dsRNA precedes the formation
of oligo A, indicate that the presence of particle-
bound dsRNA is required for oligo A formation.
The absence of oligo A in "top component" (28)
is in agreement with this hypothesis.
Inhibition of protein synthesis with cyclohexi-
mide causes rapid termination of ongoing
dsRNA synthesis (33), but allows oligo A syn-
thesis to continue for about an hour (Fig. 9).
Thus, although oligo A is not formed in the
absence of dsRNA, oligo A synthesis is not
dependent upon the concurrent synthesis of
dsRNA. That the presence of dsRNA and not its
synthesis is required for oligo A formation is
supported by our findings that oligo A synthesis
in vitro continues for about an hour (Fig. 9) and
in the presence of ATP alone, whereas the
formation of dsRNA in vitro terminates in 10 to
15 min (1) and requires the simultaneous pres-
ence of all four ribonucleoside triphosphates.
Oligo A synthesized in vitro migrates in
SDS-polyacrylamide gels slightly faster than
the in vivo product (Fig. 6). We assume that the
increased electrophoretic mobility of the in vitro
synthesized oligo A reflects a slightly shorter
chain length than the in vivo oligomer. This
conclusion is supported by the data in Table 4
which show that 52 to 71% of the 3H-ATP
incorporated into oligo A in vitro was recovered,
after alkaline digestion, in 3H-adenosine.
Thus, although a small proportion of oligo A
molecules are initiated in vitro, the major
proportion of the 3H-ATP incorporated is at the
3' end of the molecule and reflects termination
of chain growth. The data in Table 4 also
indicate that several adenine nucleotides (pAp,
ppAp, and ppAp) are recovered from the 5' end
of the in vivo and the in vitro products; Bellamy
and Hole (7) and Stolzfus and Banerjee (29)
have reported that pAp is the 5' nucleotide in in
vivo synthesized oligo A. We cannot explain
these differences. However, a similar variation
in the 5' guanosine nucleotides recovered from
in vitro synthesized ssRNA has been reported
(4, 17, 19) and has been attributed to the
presence of nucleotide phosphohydrolases
within the virion (4, 10, 16, 19).
The incorporation of 3H-UMP into a product
which co-electrophoreses with oligo A, and the
finding that about one-third of the a-32P-ATP
incorporated is recovered in UMP after alkaline
hydrolysis of the oligonucleotides indicates that
the in vitro synthesized oligo A is contaminated
with a uridylic acid-containing oligomer.
These findings raise the possibility that some
of the in vitro synthesized oligonucleotides rep-
resent breakdown products of newly formed
ssRNA's. Two observations make this possibil-
ity highly unlikely. (i) ssRNA synthesis requires
the simultaneous presence of all four rNTP's;
the oligonucleotides we have described are syn-
thesized in the presence of ATP alone. (ii)
Addition of ribonuclease to the reaction mixture
has no effect on the amount or size of oligonu-
cleotide formed. Further work will be required
to characterize the uridylic acid-containing oli-
gomer which serves, in vitro, as an acceptor for
adenine ribonucleotides. One candidate for
such an oligomer is the trinucleotide (pGpCpU)
described by Bellamy et al. (7). However, it is
clear that the major proportion (67%) of the
a-32P-ATP incorporated in vitro has as its
nearest neighbor an adenine nucleotide and
reflects the elongation or the termination of
adenylic acid oligomers, or both.
Release of both the in vivo and the in vitro
formed oligo A from the large particulate cyto-
plasmic fraction by chymotrypsin digestion is
similar to the release of oligo A from reovirions
by this enzyme (14). Moreover, the viral poly-
peptides which remain in this fraction after
chymotrypsin digestion are the same ones con-
served after digestion of reovirions. These facts
lead us to suggest that oligo A, like dsRNA (1,
20, 37), is synthesized within the maturing
virion. The presence of in vitro synthesized oligo
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FIG. 12. Effect of temperature on the synthesis of
ssRNA, dsRNA, and oligo A. An LPF was prepared
from 5 x 10' cells infected 13 h previously with
reovirus (20 PFU/cell). The fraction was resuspended
in 2 ml of RSB and used as the source of enzyme for
RNA synthesis. Incubations were conducted at 31, 37,
and 45 C. a, Samples (0.2 ml) of enzyme (equivalent
to 5 x 10' cells) were incubated for dsRNA synthesis
in 0.5-ml reaction mixtures for 5 min at the indicated
temperatures. The reactions were stopped by addition
of 1 ml of cold RSB, and the dsRNA was extracted
and precipitated. ds RNA was measured as ribonu-
clease-resistant (4 )Ag/ml) acid-insoluble radioactivity
in 0.3M NaCl as described (1). b, Samples (15 uliters)
of enzyme (equivalent to 5 x 105 cells) were incubated
for ssRNA synthesis in 0.3-ml reaction mixtures at the
CsCl, and the exclusion of oligo A from the
soluble cytoplasm of reovirus infected cells (5),
support this hypothesis.
Brief incubation of intact reovirus at elevated
temperatures activates the RNA transcriptase
within the virion, presumably by removing or
altering the outer layer of capsids (9). However,
the enhanced ssRNA synthesis at elevated tem-
peratures reported here did not result from
alterations in permeability of virions and nas-
cent particles since the LPF was incubated with
chymotrypsin prior to the measurement of
ssRNA synthesis. As noted earlier, the effect of
chymotrypsin digestion on the viral polypep-
tides within the LPF closely resembles the
effect of this enzyme on purified virions. Simi-
larly, chymotrypsin treatment of the LPF had
no effect on the rate of dsRNA synthesis at 31,
37, or 45 C. Since chymotrypsin treatment of
the LPF abolishes oligo A synthesis, similar
control experiments regarding the effect of tem-
perature on the availability of nucleotides for
oligo A formation cannot be performed. Our
finding that the ssRNA transcriptase, dsRNA
replicase, and oligo A polymerase all have the
same unusual temperature optimum (45 C)
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Synthesis of mRNA E 3VJ< Viral core proteins
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FIG. 13. Model of reovirus maturation.
temperatures indicated. At appropriate times 40 gli-
ters of the reaction mixture were analyzed for acid-
insoluble radioactivity as described (24). c, Samples
(0.4 ml) of enzyme (equivalent to 108 cells) were
incubated for oligo A synthesis in 1-ml reaction
mixtures for 30 min at the indicated temperatures.
The reaction mixtures were then centrifuged at 20,000
x g for 30 min at 4 C, and the oligo A contained in the
pellet fractions was extracted and analyzed as de-
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suggests that they are alternative activities of
the same enzyme(s). However, the inhibition of
oligo A synthesis by chymotrypsin does not
appear to be consistent with this hypothesis
since chymotrypsin stimulates the ssRNA tran-
scriptase (3, 27) and has no inhibitory effect on
the dsRNA synthetase (1). One explanation of
this apparent paradox is that activities of the
oligo A polymerase and the ssRNA transcript-
ase (2) are regulated inversely by outer capsid
proteins.
A model for the assembly of reovirions which
is consistent with these data is presented in Fig.
13. dsRNA is synthesized within the core of the
nascent virion by the formation of minus
strands on plus strand templates. As dsRNA
strands are completed, the dsRNA replicase
functions as an ssRNA transcriptase and cata-
lyzes the formation of ssRNA plus strands.
Finally, the ssRNA transcriptase is converted to
an oligo A polymerase and oligo A synthesis
commences within the maturing virion. Al-
though the initiation signal for the formation of
oligo A has not been identified, we assume that
the assembly or modification of outer capsid
proteins exerts a regulatory effect upon the
particle-bound ssRNA transcriptase, altering
its conformation and converting it to an oligo A
polymerase. A similar proposal regarding the
mechanism of oligo A formation has been made
by Nichols et al. (19).
Unfortunately, these studies have yielded no
clue to the function of reovirus oligo A. Reovi-
rions uncoated in vivo (11), or under specific
conditions in vitro (14), retain oligo A yet they
exhibit the same RNA transcriptase activity as
particles lacking these adenylic acid oligomers
(14). Neither the plus strands which function as
templates for dsRNA synthesis nor the plus
strands which serve as mRNA's contain oligo A
(31), and we have been unable to identify a
virion-bound activity which joins oligo A to the
ssRNA products of the RNA transcriptase (S.
Silverstein and G. Acs, unpublished observa-
tion). Moreover, reovirus "top component"
(which contains no RNA) is indistinguishable in
polypeptide composition from virions contain-
ing dsRNA and oligo A (28). Thus, whatever its
function, oligo A is not required for the activity
of the particle-bound RNA transcriptase, for
the formation of functional mRNA or of plus
strand precursors of dsRNA, or for the assembly
of viral proteins into virions.
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